Expression of NRP1, along with several other genes associated with SEMA3 signaling, is significantly associated with four clinicopathological characteristics, namely age, tumor grade, isocitrate dehydrogenase (IDH) mutation, and survival time, and is closely related to an unfavorable patient outcome. The gene discussed is NRP1; the disease is neoplasm.